You are currently viewing a new version of our website. To view the old version click .

Pharmaceuticals, Volume 11, Issue 2

June 2018 - 30 articles

Cover Story: Over the past few years, drug repositioning has become a relevant strategy for drug discovery, being a time and money saving process. Neurodegenerative diseases are particularly well suited for this approach, as these diseases are age-related and popular treatments of co-morbidities in these kind of pathologies can exhibit beneficial side effects. Our review “Old Drugs as New Treatments for Neurodegenerative Diseases” shows that, in this area of research, the key to the future can be found in the past, and old drugs can become effective new treatments for neurodegenerative diseases. View the paper here.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (30)

  • Article
  • Open Access
9 Citations
6,215 Views
8 Pages

Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure

  • Sally Miller,
  • Shashank Kulkarni,
  • Alex Ciesielski,
  • Spyros P. Nikas,
  • Ken Mackie,
  • Alexandros Makriyannis and
  • Alex Straiker

Nearly half a century has passed since the demonstration that cannabis and its chief psychoactive component Δ9-THC lowers intraocular pressure (IOP). Elevated IOP remains the chief hallmark and therapeutic target for glaucoma, a condition that...

  • Article
  • Open Access
7 Citations
4,665 Views
10 Pages

A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2

  • Martin Mangold,
  • Michael Gütschow and
  • Marit Stirnberg

Matriptase-2 is a type II transmembrane serine protease and a key regulator of systemic iron homeostasis. Since the activation mechanism and several features of the physiological role of matriptase-2 are not fully understood, there is strong need for...

  • Article
  • Open Access
14 Citations
6,806 Views
13 Pages

High Concentrations of Sodium Chloride Improve Microbicidal Activity of Ibuprofen against Common Cystic Fibrosis Pathogens

  • Adrián J. Muñoz,
  • Roxana V. Alasino,
  • Ariel G. Garro,
  • Valeria Heredia,
  • Néstor H. García,
  • David C. Cremonezzi and
  • Dante M. Beltramo

Ibuprofen (IBU-H), a widely used anti-inflammatory, also shows a marked antimicrobial effect against several bacterial species, including those involved in cystic fibrosis such as Pseudomona aeruginosa, methicillin resistant Staphylococcus aureus and...

  • Review
  • Open Access
68 Citations
8,368 Views
25 Pages

The Role of TRP Channels in the Metastatic Cascade

  • Benedikt Fels,
  • Etmar Bulk,
  • Zoltán Pethő and
  • Albrecht Schwab

A dysregulated cellular Ca2+ homeostasis is involved in multiple pathologies including cancer. Changes in Ca2+ signaling caused by altered fluxes through ion channels and transporters (the transportome) are involved in all steps of the metastatic cas...

  • Feature Paper
  • Article
  • Open Access
43 Citations
8,318 Views
22 Pages

Novel N4-Like Bacteriophages of Pectobacterium atrosepticum

  • Colin Buttimer,
  • Hanne Hendrix,
  • Alan Lucid,
  • Horst Neve,
  • Jean-Paul Noben,
  • Charles Franz,
  • Jim O’Mahony,
  • Rob Lavigne and
  • Aidan Coffey

Pectobacterium atrosepticum is an economically important phytopathogen that is responsible for potato blackleg and soft rot, and for which current control strategies are limited. In this study, stem samples of potato crops exhibiting blackleg were ta...

  • Article
  • Open Access
6 Citations
4,244 Views
10 Pages

The Effects of Dabigatran and Rivaroxaban on Markers of Polymorphonuclear Leukocyte Activation

  • Guy A. Richards,
  • Annette Theron,
  • Gregory Tintinger and
  • Ronald Anderson

Dabigatran is an oral direct thrombin inhibitor, and rivaroxaban, a factor Xa inhibitor. Dabigatran has been implicated in the etiology of acute coronary syndromes and as these occur following inflammatory changes in the endothelium, we investigated...

  • Review
  • Open Access
284 Citations
27,532 Views
21 Pages

Old Drugs as New Treatments for Neurodegenerative Diseases

  • Fernando Durães,
  • Madalena Pinto and
  • Emília Sousa

Neurodegenerative diseases are increasing in number, given that the general global population is becoming older. They manifest themselves through mechanisms that are not fully understood, in many cases, and impair memory, cognition and movement. Curr...

  • Article
  • Open Access
18 Citations
5,553 Views
11 Pages

This study was carried out to evaluate the anti-parasitic effect of ursolic acid against Toxoplasma gondii (T. gondii) that induces toxoplasmosis, particularly in humans. The anti-parasitic effects of ursolic acid against T. gondii-infected cells and...

  • Feature Paper
  • Review
  • Open Access
52 Citations
10,491 Views
10 Pages

2017 FDA Peptide Harvest

  • Othman Al Musaimi,
  • Danah Al Shaer,
  • Beatriz G. De la Torre and
  • Fernando Albericio

2017 was an excellent year in terms of new drugs (chemical entities and biologics) approved by the FDA, with a total of 46. In turn, one of the highlights was the number of peptides (six) included in this list. Here, the six peptides are analyzed in...

  • Article
  • Open Access
8 Citations
4,646 Views
13 Pages

Synthesis and Structure-Activity Relationships of (−)-cis-N-Normetazocine-Based LP1 Derivatives

  • Lorella Pasquinucci,
  • Carmela Parenti,
  • Emanuele Amata,
  • Zafiroula Georgoussi,
  • Paschalina Pallaki,
  • Valeria Camarda,
  • Girolamo Calò,
  • Emanuela Arena,
  • Lucia Montenegro and
  • Rita Turnaturi

(−)-cis-N-Normetazocine represents a rigid scaffold able to mimic the tyramine moiety of endogenous opioid peptides, and the introduction of different N-substituents influences affinity and efficacy of respective ligands at MOR (mu opioid recep...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247